{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:30:08Z","timestamp":1793813408975,"version":"4.6.1"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ibroneuroreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IBRO Neuroscience Reports"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ibneur.2026.06.007","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T18:26:00Z","timestamp":1781461560000},"page":"122-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Unlocking the healing power of Berberine: A promising aid for multiple sclerosis"],"prefix":"10.1016","volume":"21","author":[{"given":"Amir Modarresi","family":"Chahardehi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Karimi Khordeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narges Moazeni","family":"Limoudehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hediyeh","family":"Dasoomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razie","family":"Omrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadhadi","family":"Nikjoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham Mortazavi","family":"Mamaghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Saeed Soleimani","family":"Meigoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Shoja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Jafari-Ardakan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Arefnezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1402-6482","authenticated-orcid":false,"given":"Fatemeh","family":"Rezaei-Tazangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ibneur.2026.06.007_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.762654","article-title":"Berberine: a review of its pharmacokinetics properties and therapeutic potentials in diverse vascular diseases","volume":"12","author":"Ai","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.ibneur.2026.06.007_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13936","article-title":"Neuroprotective potential of Berberine in modulating Alzheimer\u2019s disease via multiple signaling pathways","volume":"45","author":"Akbar","year":"2021","journal-title":"J. Food Biochem."},{"issue":"23","key":"10.1016\/j.ibneur.2026.06.007_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252312906","article-title":"Genes, Gene Loci, and their impacts on the immune system in the development of multiple sclerosis: a systematic review","volume":"25","author":"Arneth","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.ibneur.2026.06.007_bib4","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2174\/1389450121666200621193758","article-title":"Berberine administration in treatment of colitis: a review","volume":"21","author":"Ashrafizadeh","year":"2020","journal-title":"Curr. Drug. Targets"},{"issue":"6","key":"10.1016\/j.ibneur.2026.06.007_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13061813","article-title":"Long-term disability outcomes in relapsing-remitting multiple sclerosis patients: impact of clinical and demographic factors on disease progression","volume":"13","author":"Barcutean","year":"2024","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.ibneur.2026.06.007_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00210-024-03326-x","article-title":"Effects of Berberis vulgaris, and its active constituent Berberine on cytochrome P450: a review","volume":"398","author":"Bathaei","year":"2025","journal-title":"Naunyn Schmiede Arch. Pharmacol."},{"issue":"8","key":"10.1016\/j.ibneur.2026.06.007_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202500170","article-title":"Unraveling Berberine's molecular mechanisms in neuroprotection against neurodegeneration","volume":"22","author":"Begh","year":"2025","journal-title":"Chem. Biodivers."},{"issue":"1","key":"10.1016\/j.ibneur.2026.06.007_bib8","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1038\/s41467-025-57488-0","article-title":"Berberine-inspired ionizable lipid for self-structure stabilization and brain targeting delivery of nucleic acid therapeutics","volume":"16","author":"Bian","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ibneur.2026.06.007_bib9","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/cpt.3454","article-title":"Sex-dependent effects of CYP2D6 on the pharmacokinetics of Berberine in humans","volume":"117","author":"Blocher","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ibneur.2026.06.007_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3897\/pharmacia.72.e153730","article-title":"In vitro evaluation of antioxidant and neuroprotective effects of Berberine loaded in nanostructured lipid carriers","volume":"72","author":"Bogdanova","year":"2025","journal-title":"Pharmacia"},{"issue":"6","key":"10.1016\/j.ibneur.2026.06.007_bib11","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1194\/jlr.M600020-JLR200","article-title":"Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of Berberine","volume":"47","author":"Brusq","year":"2006","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.ibneur.2026.06.007_bib12","first-page":"201","article-title":"Displacement of bilirubin from albumin by Berberine","volume":"63","author":"Chan","year":"1993","journal-title":"Biol. Neonate"},{"key":"10.1016\/j.ibneur.2026.06.007_bib13","article-title":"From nature to nanotech: unlocking Berberine's therapeutic approaches","volume":"108","author":"Chaudhari","year":"2025","journal-title":"J. Drug. Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.ibneur.2026.06.007_bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.intimp.2011.10.019","article-title":"Berberine induces heme oxygenase-1 up-regulation through phosphatidylinositol 3-kinase\/AKT and NF-E2-related factor-2 signaling pathway in astrocytes","volume":"12","author":"Chen","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ibneur.2026.06.007_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.845591","article-title":"Berberine: a promising treatment for neurodegenerative diseases","volume":"13","author":"Cheng","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.ibneur.2026.06.007_bib16","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/emm.2006.71","article-title":"Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte","volume":"38","author":"Choi","year":"2006","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ibneur.2026.06.007_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/145325","article-title":"Cyclosporine and herbal supplement interactions","volume":"2014","author":"Colombo","year":"2014","journal-title":"J. Toxicol."},{"issue":"19","key":"10.1016\/j.ibneur.2026.06.007_bib18","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.3390\/jcm13195687","article-title":"Picturing the multiple sclerosis patient journey: a symptomatic overview","volume":"13","author":"Correia","year":"2024","journal-title":"J. Clin. Med."},{"issue":"8","key":"10.1016\/j.ibneur.2026.06.007_bib19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/WNL.0000000000012323","article-title":"Secondary progressive multiple sclerosis","volume":"97","author":"Cree","year":"2021","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ibneur.2026.06.007_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1474-4422(22)00040-0","article-title":"Multiple sclerosis: two decades of progress","volume":"21","author":"Cree","year":"2022","journal-title":"Lancet Neurol."},{"issue":"41","key":"10.1016\/j.ibneur.2026.06.007_bib21","doi-asserted-by":"crossref","first-page":"28420","DOI":"10.1074\/jbc.M109.012674","article-title":"Berberine differentially modulates the activities of ERK, p38 MAPK, and JNK to suppress Th17 and Th1 T cell differentiation in type 1 diabetic mice","volume":"284","author":"Cui","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ibneur.2026.06.007_bib22","article-title":"Neuroprotective effects and possible mechanisms of Berberine in animal models of Alzheimer's disease: a systematic review and meta-analysis","volume":"14","author":"Dan","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ibneur.2026.06.007_bib23","article-title":"An overview of the history, pathophysiology, and pharmacological interventions of multiple sclerosis","volume":"15","author":"Dighriri","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.ibneur.2026.06.007_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106270","article-title":"Effect of Berberine on spleen transcriptome and gut microbiota composition in experimental autoimmune uveitis","volume":"81","author":"Du","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"23","key":"10.1016\/j.ibneur.2026.06.007_bib25","doi-asserted-by":"crossref","first-page":"13573","DOI":"10.1111\/jcmm.16049","article-title":"Anti-inflammatory and immune-modulatory impacts of Berberine on activation of autoreactive T cells in autoimmune inflammation","volume":"24","author":"Ehteshamfar","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"4","key":"10.1016\/j.ibneur.2026.06.007_bib26","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7861\/clinmed.2020-0292","article-title":"Clinical presentation and diagnosis of multiple sclerosis","volume":"20","author":"Ford","year":"2020","journal-title":"Clin. Med."},{"issue":"3","key":"10.1016\/j.ibneur.2026.06.007_bib27","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jtcme.2020.02.009","article-title":"The \"Treatise on the spleen and stomach\" (Pi Wei Lun) as the first record of multiple sclerosis in the medical literature - a hypothesis based on the analysis of clinical presentation and herbal medicine","volume":"10","author":"Fuzimoto","year":"2020","journal-title":"J. Tradit. Complement. Med."},{"issue":"7","key":"10.1016\/j.ibneur.2026.06.007_bib28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2174\/1389203724666230717124101","article-title":"The fulcrum of demyelination in multiple sclerosis","volume":"24","author":"Ganesan","year":"2023","journal-title":"Curr. Protein Pept. Sci."},{"issue":"19","key":"10.1016\/j.ibneur.2026.06.007_bib29","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.3390\/molecules29194576","article-title":"A descriptive review of the antioxidant effects and mechanisms of action of Berberine and Silymarin","volume":"29","author":"Garc\u00eda-Mu\u00f1oz","year":"2024","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ibneur.2026.06.007_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/cbdd.14231","article-title":"Current understanding and future prospects on Berberine for anticancer therapy","volume":"102","author":"Goel","year":"2023","journal-title":"Chem. Biol. Drug. Des."},{"issue":"8","key":"10.1016\/j.ibneur.2026.06.007_bib31","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000037297","article-title":"Review of multiple sclerosis: epidemiology, etiology, pathophysiology, and treatment","volume":"103","author":"Haki","year":"2024","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.ibneur.2026.06.007_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1089\/jmf.2011.2029","article-title":"Berberine promotes axonal regeneration in injured nerves of the peripheral nervous system","volume":"15","author":"Han","year":"2012","journal-title":"J. Med. Food"},{"key":"10.1016\/j.ibneur.2026.06.007_bib33","article-title":"Berberine-loaded iron oxide nanoparticles alleviate cuprizone-induced astrocytic reactivity in a rat model of multiple sclerosis","author":"Ibrahim Fouad","year":"2024","journal-title":"Biometals"},{"key":"10.1016\/j.ibneur.2026.06.007_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102510","article-title":"The current status and challenges in multiple sclerosis management in the Philippines","volume":"46","author":"Ignacio","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.ibneur.2026.06.007_bib35","series-title":"Oxidative Stress and Dietary Antioxidants in Neurological Diseases","first-page":"199","article-title":"Chapter 14 - Berberine neuroprotection and antioxidant activity","author":"Imenshahidi","year":"2020"},{"issue":"5","key":"10.1016\/j.ibneur.2026.06.007_bib36","first-page":"954","article-title":"Multiple sclerosis: new insights and trends","volume":"27","author":"Inglese","year":"2006","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"4","key":"10.1016\/j.ibneur.2026.06.007_bib37","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1179\/1743132812Y.0000000156","article-title":"The protective effect of Berberine against neuronal damage by inhibiting matrix metalloproteinase-9 and laminin degradation in experimental autoimmune encephalomyelitis","volume":"35","author":"Jiang","year":"2013","journal-title":"Neurol. Res."},{"issue":"11","key":"10.1016\/j.ibneur.2026.06.007_bib38","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1002\/ptr.7589","article-title":"Pharmacokinetic of Berberine, the main constituent of Berberis vulgaris L.: a comprehensive review","volume":"36","author":"Khoshandam","year":"2022","journal-title":"Phytother. Res."},{"issue":"9","key":"10.1016\/j.ibneur.2026.06.007_bib39","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028928","article-title":"Clinical course of multiple sclerosis","volume":"8","author":"Klineova","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ibneur.2026.06.007_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2022.1095208","article-title":"Editorial: measuring progression in multiple sclerosis: progressing beyond the ordinary","volume":"16","author":"Koch","year":"2022","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.ibneur.2026.06.007_bib41","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejphar.2015.05.068","article-title":"Current knowledge and pharmacological profile of Berberine: an update","volume":"761","author":"Kumar","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"38","key":"10.1016\/j.ibneur.2026.06.007_bib42","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1021\/jf302832n","article-title":"Berberine, an isoquinoline alkaloid, inhibits the metastatic potential of breast cancer cells via Akt pathway modulation","volume":"60","author":"Kuo","year":"2012","journal-title":"J. Agric. Food Chem."},{"issue":"9","key":"10.1016\/j.ibneur.2026.06.007_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107129","article-title":"Mitochondria and NMDA receptor-dependent toxicity of Berberine sensitizes neurons to glutamate and rotenone injury","volume":"9","author":"Kysenius","year":"2014","journal-title":"PLoS. One"},{"issue":"8","key":"10.1016\/j.ibneur.2026.06.007_bib44","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.2337\/db06-0006","article-title":"Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states","volume":"55","author":"Lee","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.ibneur.2026.06.007_bib45","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12967-015-0629-3","article-title":"Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters","volume":"13","author":"Li","year":"2015","journal-title":"J. Transl. Med."},{"issue":"21","key":"10.1016\/j.ibneur.2026.06.007_bib46","first-page":"4066","article-title":"Effects of Berberine on serum inflammatory factors and carotid atherosclerotic plaques in patients with acute cerebral ischemic stroke","volume":"41","author":"Li","year":"2016","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"4","key":"10.1016\/j.ibneur.2026.06.007_bib47","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00406-021-01359-4","article-title":"Improvement of adjunctive Berberine treatment on negative symptoms in patients with schizophrenia","volume":"272","author":"Li","year":"2022","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.ibneur.2026.06.007_bib48","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/ptr.7806","article-title":"Berberine and health outcomes: an umbrella review","volume":"37","author":"Li","year":"2023","journal-title":"Phytother. Res."},{"key":"10.1016\/j.ibneur.2026.06.007_bib49","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.biopha.2016.02.015","article-title":"Protective mechanisms of Berberine against experimental autoimmune myocarditis in a rat model","volume":"79","author":"Liu","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.ibneur.2026.06.007_bib50","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.bbrc.2017.06.142","article-title":"The effects of Berberine on a murine model of multiple sclerosis and the SPHK1\/S1P signaling pathway","volume":"490","author":"Luo","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.ibneur.2026.06.007_bib51","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1002\/ptr.7920","article-title":"Effects of adjuvant Berberine therapy on acute ischemic stroke: a meta-analysis","volume":"37","author":"Luo","year":"2023","journal-title":"Phytother. Res."},{"issue":"10","key":"10.1016\/j.ibneur.2026.06.007_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013489","article-title":"Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL\/6 mice","volume":"5","author":"Ma","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ibneur.2026.06.007_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.prmcm.2025.100689","article-title":"Targeting AMPK signaling: the therapeutic potential of Berberine in diabetes and its complications","volume":"17","author":"Mbara","year":"2025","journal-title":"Pharmacol. Res. Mod. Chin. Med."},{"issue":"2","key":"10.1016\/j.ibneur.2026.06.007_bib54","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s12035-013-8559-7","article-title":"Berberine ameliorate oxidative stress and astrogliosis in the hippocampus of STZ-induced diabetic rats","volume":"49","author":"Moghaddam","year":"2014","journal-title":"Mol. Neurobiol."},{"issue":"10","key":"10.1016\/j.ibneur.2026.06.007_bib55","first-page":"712","article-title":"Multiple sclerosis","volume":"87","author":"Nicholas","year":"2013","journal-title":"Am. Fam. Physician"},{"issue":"11","key":"10.1016\/j.ibneur.2026.06.007_bib56","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3390\/toxins12110713","article-title":"Biological activity of Berberine\u2014a summary update","volume":"12","author":"Och","year":"2020","journal-title":"Toxins"},{"issue":"4","key":"10.1016\/j.ibneur.2026.06.007_bib57","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/CON.0000000000001156","article-title":"Diagnosis of multiple sclerosis","volume":"28","author":"Oh","year":"2022","journal-title":"Continuum"},{"key":"10.1016\/j.ibneur.2026.06.007_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102815","article-title":"Multiple sclerosis and aging: comorbidity and treatment challenges","volume":"50","author":"Ostolaza","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.ibneur.2026.06.007_bib59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11033-025-11193-9","article-title":"Nanomedicine-enabled neuroprotection: therapeutic role of Berberine in neurodegenerative diseases","volume":"53","author":"Pal","year":"2025","journal-title":"Mol. Biol. Rep."},{"issue":"Q4","key":"10.1016\/j.ibneur.2026.06.007_bib60","doi-asserted-by":"crossref","first-page":"355","DOI":"10.7224\/1537-2073.2023-061","article-title":"Ballroom dancing for people with multiple sclerosis: perceptions of the experience","volume":"26","author":"Piacentine","year":"2024","journal-title":"Int. J. MS Care"},{"key":"10.1016\/j.ibneur.2026.06.007_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1210091","article-title":"Neurodegeneration and its potential markers in the diagnosing of secondary progressive multiple sclerosis. A review","volume":"16","author":"Pogoda-Weso\u0142owska","year":"2023","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.ibneur.2026.06.007_bib62","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13020-023-00746-4","article-title":"Berberine improves negative symptoms and cognitive function in patients with chronic schizophrenia via anti-inflammatory effect: a randomized clinical trial","volume":"18","author":"Pu","year":"2023","journal-title":"Chin. Med."},{"issue":"3","key":"10.1016\/j.ibneur.2026.06.007_bib63","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.4049\/jimmunol.0903853","article-title":"Regulation of Th1 and Th17 cell differentiation and amelioration of experimental autoimmune encephalomyelitis by natural product compound Berberine","volume":"185","author":"Qin","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.ibneur.2026.06.007_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112422","article-title":"Berberine, a natural alkaloid: advances in its pharmacological effects and mechanisms in the treatment of autoimmune diseases","volume":"137","author":"Qin","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.ibneur.2026.06.007_bib65","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/1352458514541976","article-title":"Progression rates and sample size estimates for PPMS based on the CLIMB study population","volume":"21","author":"Raghavan","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.ibneur.2026.06.007_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.msard.2018.02.024","article-title":"A systematic review about the epidemiology of primary progressive multiple sclerosis in Latin America and the Caribbean","volume":"22","author":"Rojas","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.ibneur.2026.06.007_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157754","article-title":"Characterisation of transcriptional changes in the spinal cord of the progressive experimental autoimmune encephalomyelitis Biozzi ABH mouse model by RNA sequencing","volume":"11","author":"Sevastou","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ibneur.2026.06.007_bib68","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3390\/cells11050796","article-title":"Therapeutic efficacies of Berberine against neurological disorders: an update of pharmacological effects and mechanisms","volume":"11","author":"Shou","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ibneur.2026.06.007_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577787","article-title":"Berberine attenuates experimental autoimmune myasthenia gravis via rebalancing the T cell subsets","volume":"362","author":"Song","year":"2022","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.ibneur.2026.06.007_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17030331","article-title":"In vitro evaluation of the safety and antineoplastic effects in gastrointestinal tumors of nanostructured lipid carriers loaded with Berberine","volume":"17","author":"Stefanova","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ibneur.2026.06.007_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1429050","article-title":"Neuroprotective effect and preparation methods of Berberine","volume":"15","author":"Sunhe","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ibneur.2026.06.007_bib72","unstructured":"Tafti, D., M. Ehsan, and K.L. Xixis, Multiple Sclerosis, in StatPearls. 2024: Treasure Island (FL) ineligible companies. Disclosure: Moavia Ehsan declares no relevant financial relationships with ineligible companies. Disclosure: Kathryn Xixis declares no relevant financial relationships with ineligible companies.(n.d.)."},{"issue":"1","key":"10.1016\/j.ibneur.2026.06.007_bib73","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.766","article-title":"Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells","volume":"11","author":"Tavaf","year":"2023","journal-title":"Immun. Inflamm. Dis."},{"issue":"2","key":"10.1016\/j.ibneur.2026.06.007_bib74","first-page":"64","article-title":"Neurodevelopmental abnormalities in children associated with maternal use of psychoactive medication: maternal use of psychoactive medication","volume":"1","author":"Tawfeeq","year":"2022","journal-title":"Med. Pharm. J."},{"issue":"10130","key":"10.1016\/j.ibneur.2026.06.007_bib75","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ibneur.2026.06.007_bib76","doi-asserted-by":"crossref","first-page":"199","DOI":"10.31128\/AJGP-07-21-6103","article-title":"Multiple sclerosis: diagnosis, disease-modifying therapy and prognosis","volume":"51","author":"Travers","year":"2022","journal-title":"Aust. J. Gen. Pract."},{"key":"10.1016\/j.ibneur.2026.06.007_bib77","first-page":"S15","article-title":"Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis","volume":"19","author":"Tullman","year":"2013","journal-title":"Am. J. Manag. Care"},{"issue":"6","key":"10.1016\/j.ibneur.2026.06.007_bib78","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41582-019-0183-3","article-title":"Epidemiology and treatment of multiple sclerosis in elderly populations","volume":"15","author":"Vaughn","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"7","key":"10.1016\/j.ibneur.2026.06.007_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073522","article-title":"Berberine delays onset of collagen-induced arthritis through T cell suppression","volume":"22","author":"Vita","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ibneur.2026.06.007_bib80","first-page":"125","article-title":"An experimental study on the photodynamic activity of Berberine in vitro on cancer cells","volume":"6","author":"Wang","year":"1986","journal-title":"J. Tradit. Chin. Med. Chung i tsa Chih Ying Wen Pan"},{"key":"10.1016\/j.ibneur.2026.06.007_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106205","article-title":"Berberine combined with cyclosporine A alleviates acute graft-versus-host disease in murine models","volume":"81","author":"Wang","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.ibneur.2026.06.007_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1213","article-title":"Berberine: a natural modulator of immune cells in multiple sclerosis","volume":"12","author":"Yazdanpanah","year":"2024","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.ibneur.2026.06.007_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1457788","article-title":"Global prevalence of fatigue in patients with multiple sclerosis: a systematic review and meta-analysis","volume":"15","author":"Yi","year":"2024","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.ibneur.2026.06.007_bib84","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1038\/s41467-020-18414-8","article-title":"Gut microbiome-related effects of Berberine and probiotics on type 2 diabetes (the PREMOTE study)","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat. Commun."}],"container-title":["IBRO Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242126000874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242126000874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:36:34Z","timestamp":1793810194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667242126000874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":84,"alternative-id":["S2667242126000874"],"URL":"https:\/\/doi.org\/10.1016\/j.ibneur.2026.06.007","relation":{},"ISSN":["2667-2421"],"issn-type":[{"value":"2667-2421","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unlocking the healing power of Berberine: A promising aid for multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"IBRO Neuroscience Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ibneur.2026.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Brain Research Organization.","name":"copyright","label":"Copyright"}]}}